{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:46:38Z","timestamp":1778939198936,"version":"3.51.4"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>Management of hemolytic disease of the fetus and newborn relies on monitoring of maternal antibody titers, fetal ultrasound, and fetal middle cerebral artery peak systolic velocity studies and is generally treated by intrauterine transfusion (IUT). Few studies have explored fetal and neonate physiological responses to IUT. Our objective was to examine fetal erythropoietic response and to examine neonatal erythropoietic effects after treatment. Thirty-six patients treated from 2005 to 2015 were identified retroactively. The time course of treatment, including gestational age and number of IUT, and timing of delivery were reviewed. Fetal reticulocyte count and neonatal hemoglobin and reticulocyte counts were analyzed for each IUT. For each gestational week, reticulocyte count decreased by \u223c8.6% (95% confidence interval [CI]: 5.3-12.0). In the neonatal period, there was significant correlation between hemoglobin at birth and number of transfusions (Spearman correlation 0.473, 95% CI: 0.113-0.715, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.01) as well as reticulocyte count at birth and number of transfusions (Spearman correlation: 0.393, 95% CI: 0.058-0.642, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.02). IUT appears to have a direct and measurable effect on fetal reticulocyte production which persists in neonates.<\/jats:p>","DOI":"10.1097\/mph.0000000000002450","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:09:53Z","timestamp":1649153393000},"page":"e1046-e1049","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Fetal and Neonatal Reticulocyte Count Response to Intrauterine Transfusion for the Treatment of Red Blood Cell Alloimmunization"],"prefix":"10.1097","volume":"44","author":[{"given":"Alan J.","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Ohio State College of Medicine Wexner Medical Center, Columbus"},{"name":"Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Leonard","sequence":"additional","affiliation":[{"name":"Department of Environmental and Public Health, Ohio University of Cincinnati School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara B.","family":"Markham","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, The Ohio State College of Medicine Wexner Medical Center, Columbus"},{"name":"Department of Obstetrics and Gynecology, Ohio University of Cincinnati Health, Cincinnati, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"R1-20250804","first-page":"1","article-title":"Births: final data for 2002","volume":"52","author":"Martin","year":"2003","journal-title":"Natl Vital Stat Rep"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0029-7844(96)00434-6","article-title":"Female alloimmunization with antibodies known to cause hemolytic disease","volume":"89","author":"Geifman-Holtzman","year":"1997","journal-title":"Obstet Gynecol"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1365-2141.1995.tb05425.x","article-title":"A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion","volume":"91","author":"Heddle","year":"1995","journal-title":"Br J Haematol"},{"key":"R4-20250804","first-page":"216","article-title":"A prospective study of the incidence of red cell allo-immunisation following transfusion","volume":"71","author":"Redman","year":"1996","journal-title":"Vox Sang"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1537-2995.1990.30690333485.x","article-title":"Incidence of red cell antibodies after multiple blood transfusion","volume":"30","author":"Fluit","year":"1990","journal-title":"Transfusion"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1537-2995.1999.39070763.x","article-title":"Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases","volume":"39","author":"Schonewille","year":"1999","journal-title":"Transfusion"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1537-2995.1988.28588337338.x","article-title":"Red cell alloimmunization in multitransfused HLA-typed patients","volume":"28","author":"Brantley","year":"1988","journal-title":"Transfusion"},{"key":"R8-20250804","first-page":"e129","article-title":"Hemolytic disease of the fetus and newborn due to intravenous drug use","volume":"1","author":"Markham","year":"2016","journal-title":"AJP Rep"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/uog.1886","article-title":"Prediction of fetal anemia in pregnancies with red-cell alloimmunization: comparison of middle cerebral artery peak systolic velocity and amniotic fluid OD450","volume":"25","author":"Bullock","year":"2005","journal-title":"Ultrasound in Obstet Gynecol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0029-7844(96)00113-5","article-title":"Fetal transfusion for red blood cell alloimmunization in pregnancy","volume":"88","author":"Schumacher","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1067\/mob.2001.116690","article-title":"The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment","volume":"185","author":"van Kamp","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00404-015-3915-7","article-title":"Perinatal survival and procedure-related complications after intrauterine transfusion for red cell alloimmunization","volume":"293","author":"Deka","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/pd.4152","article-title":"Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review","volume":"33","author":"Lindenburg","year":"2013","journal-title":"Prenat Diagn"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3476(05)81096-0","article-title":"Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization","volume":"117","author":"Millard","year":"1990","journal-title":"J Pediatr"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000263816","article-title":"Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions","volume":"8","author":"Saade","year":"1993","journal-title":"Fetal Diagn Ther"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"119.e1","DOI":"10.1016\/j.ajog.2020.01.028","article-title":"Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions","volume":"223","author":"Ree","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0002-9378(89)90664-9","article-title":"Cordocentesis in the investigation of fetal erythropoiesis","volume":"161","author":"Nicolaides","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9378(96)70425-8","article-title":"Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia","volume":"174","author":"Weiner","year":"1996","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002450","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:02:50Z","timestamp":1754337770000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002450","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,30]]},"assertion":[{"value":"2021-08-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}